These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33047725)

  • 41. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
    Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
    Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of serum semaphorin 3A and interleukin 6 levels in patients with pseudoexfoliation syndrome.
    Okutucu M; Arpa M
    Int Ophthalmol; 2023 Jun; 43(6):1995-2002. PubMed ID: 36445548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis.
    Yao Q; Altman RD; Wang X
    J Clin Rheumatol; 2012 Jan; 18(1):28-32. PubMed ID: 22157271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Is the target of anti-cardiolipin antibodies the same in Gougerot-Sjögren syndrome and lupus erythematosus disseminatus?].
    Moysan JF; Jouquan J; Gérard C; Pennec Y; Le Goff P; Youinou P
    Rev Med Interne; 1987; 8(2):163-8. PubMed ID: 3495841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-proteasome activator 28alpha is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sjögren's syndrome.
    Matsushita M; Matsudaira R; Ikeda K; Nawata M; Tamura N; Takasaki Y
    Mod Rheumatol; 2009; 19(6):622-8. PubMed ID: 19688289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study.
    Li J; Peng L; Wu L; Ding Y; Duan X; Xu J; Wei W; Chen Z; Zhao C; Yang M; Jiang N; Zhang S; Wang Q; Tian X; Li M; Zeng X; Zhao Y; Zhao J
    Arthritis Res Ther; 2024 Mar; 26(1):67. PubMed ID: 38475924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes of serum BAFF and IL-21 levels in patients with systemic lupus erythematosus and their clinical significance].
    Wang XF; Yuan SL; Jiang L; Zhang XL; Li SF; Guo Y; Wu CL; Chen JJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1041-2. PubMed ID: 17988587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases.
    Kotajima L; Aotsuka S; Sato T
    Clin Exp Rheumatol; 1997; 15(1):59-65. PubMed ID: 9093774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Julkunen H; Siren MK; Kaaja R; Kurki P; Friman C; Koskimies S
    Br J Rheumatol; 1995 Oct; 34(10):901-7. PubMed ID: 7582692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Detecting anti-megakaryocyte antibodies in serum of systemic lupus erythematosus patients by indirect immunofluorescence].
    Luo XY; Wu LJ; Chen L; Yang MH; Liu NT; Ku-Er B; Xie CM; Shi RG; Tang Z; Zhao Y; Zeng XF; Yuan GH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):734-7. PubMed ID: 21729561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relationship between anti-ENO1 antibody and systemic lupus erythematosus patients with retinopathy].
    Zhang LQ; Zhao J; Wang HY; Wang ZY; Li YN; Tang JY; Li SY; Qu JF; Zhao MW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1099-1105. PubMed ID: 36533339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
    McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS.
    Sutcliffe N; Stoll T; Pyke S; Isenberg DA
    J Rheumatol; 1998 Jan; 25(1):63-8. PubMed ID: 9458204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.
    Kuwana M; Kaburaki J; Okazaki Y; Miyazaki H; Ikeda Y
    Rheumatology (Oxford); 2006 Jul; 45(7):851-4. PubMed ID: 16418192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of thiol/disulfide hemostasis and serum Ischemia modified albumin as oxidative stress biomarkers in systemic lupus erythematosus patients: Relationship with major organ involvement and disease activity.
    Ermurat S; Güler Kazanci E; Toka DI; Ayar K; Eren FK; Neşelioğlu S
    Lupus; 2022 Oct; 31(11):1355-1366. PubMed ID: 35850631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study.
    Sincer İ; Kurtoğlu E; Yılmaz Çoşkun F; Aktürk S; Vuruşkan E; Düzen İV; Saraçoğlu E; Aktürk E; Hidayet Ş
    Anatol J Cardiol; 2015 Nov; 15(11):913-8. PubMed ID: 25868041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.